DMDiana Mieliauskaite

Diana Mieliauskaite

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Diana Mieliauskaite has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Irena Dumalakiene

    Department of Experimental and Clinical Medicine, State Research Institute Center for Innovative Medicine, Zygimantu Street 9, 01102 Vilnius, Lithuania

    2 shared publications
  • Zygmunt Mackiewicz

    2 shared publications
  • Algirdas Venalis

    Institute of Experimental and Clinical Medicine at Vilnius University, Vilnius, Lithuania

    1 shared publication
  • Algirdas Venalis

    The Clinic of Rheumatology, Traumatology Orthopaedics and Reconstructive Surgery, Institute of Clinical Medicine of the Faculty of Vilnius University, M. K. Čiurlionio Str. 21, 03101 Vilnius, Lithuania

    1 shared publication
  • Almantas Siaurys

    1 shared publication
  • Gailute Kirdaite

    Department of Personalised Medicine, State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania

    1 shared publication

Latest Publications

    • 21 February 2013
      • Vol. 27  (2) , 263-8

    Activity of T-helper cells in patients with primary Sjogren's syndrome.

    by Gintaras Sudzius, Diana Mieliauskaite, Irena Butrimiene, Almantas Siaurys, Zygmunt Mackiewicz, Irena Dumalakiene

    To investigate the T-helper (Th1, Th2 and Th17) cell activity in the peripheral blood of patients with primary Sjögren's syndrome (pSS), non-Sjögren's sicca syndrome (nSS) and healthy controls. Peripheral blood mononuclear cells from 34 pSS, 13 nSS patients and 13 healthy controls were stimulated, labeled for cluster of differentiation-4 (CD4), interferon-γ (IFN-γ), interleukin-4 (IL-4) and IL-17A and analyzed by flow cytometry. The activities of Th1 and Th17 cells in patients with pSS were similar to those of the control group. The percentage of both IFN-γ- and IL-17-producing Th17/Th1-like cells was significantly higher in the pSS, as compared to the control group, whereas that of Th2 cells was lower. A significant correlation was found between all Th-subset activities in the control group. However, in the pSS group, a correlation was found only between Th1 with Th2 and Th17 and Th17 with Th17/Th1-like. The imbalance in Th-subset activities in peripheral blood may play a role in the pathogenesis of pSS.


  • Open Access

    Expression of IL-17, IL-23 and Their Receptors in Minor Salivary Glands of Patients with Primary Sjögren's Syndrome

    by Diana Mieliauskaite, Irena Dumalakiene, Rita Rugiene, Zygmunt Mackiewicz

    The main purpose of this study was to determine the expression of interleukins-17/-23 (ILs-17/-23) and receptors of interleukins-17/-23 (IL-17R, IL-23R) in minor salivary glands (MSGs) of patients with primary Sjögren's syndrome (pSS). Expression of IL-17, IL-23 and receptors of IL-17/-23 was analyzed in MSGs from 25 patients with pSS, 25 patients with probable preclinical pSS, and 25 patients with nonautoimmune sicca syndrome by immunohistochemistry. Comparison of the expression of IL-17, IL-23 and receptors of IL-17, IL-23 in MSG of patients with pSS with probable preclinical pSS, and with nonautoimmune sicca syndrome showed significant differences between three groups. However, the expression of IL-17, IL-23 and receptors of IL-17/-23 in MSG was comparable in pSS and probable preclinical pSS patients. We did not find correlation between the expression of IL-17 and IL-23 and of IL-17R and IL-23R in patients with pSS. These results demonstrate an involvement of IL-17/-23 system in the early pSS pathogenesis.


  • Relationship between serum levels of TGF-β1 and clinical parameters in patients with rheumatoid arthritis and Sjögren's syndrome secondary to rheumatoid arthritis

    by Diana Mieliauskaite, Paulius Venalis, Irena Dumalakiene, Algirdas Venalis, Jörg Distler

    TGF-β1 is a pleiotropic cytokine, which prevents inappropriate autoimmune responses and balances the requirements of proper immune cell levels during pathologic states that trigger the immune response. We assessed the serum levels of TGF-β1 and determined the relationship between TGF-β1 and clinical parameters in patients with rheumatoid arthritis (RA) and Sjögren's syndrome (SS) secondary to RA (SS + RA). Comparison of the serum levels of TGF-β1 in patients with RA, SS + RA and NHD differed significantly (51.7 ± 12.4 ng/ml (RA); 33.0 ± 3.1 ng/ml (SS + RA) and versus 31.6 ± 2.0 ng/ml (NHD)). We further found correlations between TGF-β1 levels and radiologically defined joint damage determined by the Steinbrocker scoring system, symptoms and signs of SS. We conclude that serum levels of TGF-β1 may reflect ongoing autoimmune inflammation and correlate with joint damage in RA.


  • Bilateral parotid enlargement due to malnutrition under the influence of the media in an adolescent in Lithuania

    by Diana Mieliauskaite, Algirdas Venalis, Vida Graziene, Gailute Kirdaite